LIJENTA-M 2.5 mg + 850 mg contains Linagliptin 2.5 mg + Metformin Hydrochloride 850 mg. It is a combination oral antidiabetic medicine used to improve blood glucose control in adults with type 2 diabetes mellitus. Linagliptin helps regulate blood sugar by increasing insulin release and reducing glucose production, while metformin improves insulin sensitivity and decreases glucose production in the liver.
Uses:
Management of type 2 diabetes mellitus
Helps control blood glucose levels along with diet and exercise
Used when metformin alone or other antidiabetic treatments are not sufficient
Helps maintain better long-term glycemic control
Dose:
Adults: Usually 1 tablet once or twice daily with meals, or as directed by a physician
Take with food to reduce gastrointestinal discomfort
Dose may be adjusted according to blood glucose levels, kidney function, and treatment response
Swallow the tablet as directed; do not crush or chew if it is an extended-release formulation
Do not stop or change the dose without medical advice
Regular monitoring of blood glucose and kidney function may be required during treatment